Keith Katkin Emergent Bio Solutions Inc. (EBS) insider trading activity

EBS Quotes by TradingView

Keith Katkin is Director of Emergent BioSolutions Inc.. Currently has a direct ownership of 59,872 shares of EBS, which is worth approximately $486,759. The most recent transaction as insider was on May 23, 2024, when has been sold 17,430 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59.9K
41.07% 3M change
41.07% 12M change
Total Value Held $486,759

Keith Katkin Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 23 2024
BUY
Grant, award, or other acquisition
-
17,430 Added 22.55%
59,872 Common Stock
May 25 2023
BUY
Grant, award, or other acquisition
-
33,847 Added 44.37%
42,442 Common Stock
Apr 02 2022
BUY
Grant, award, or other acquisition
-
8,595 Added 50.0%
8,595 Common Stock

Also insider at

SNDX
Syndax Pharmaceuticals Inc Healthcare
RIGL
RIGEL PHARMACEUTICALS INC Healthcare
Director
ELDN
Eledon Pharmaceuticals, Inc. Healthcare
Director
KK

Keith Katkin

Director
Gaithersburg, MD

Track Institutional and Insider Activities on EBS

Follow Emergent BioSolutions Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EBS shares.

Notify only if

Insider Trading

Get notified when an Emergent Bio Solutions Inc. insider buys or sells EBS shares.

Notify only if

News

Receive news related to Emergent BioSolutions Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EBS